Key result
Total arterial revascularization links to ~1.5 fewer hospital days and better 6-month symptoms versus conventional CABG.
Why the study?
The superiority of total arterial revascularization over conventional CABG remains a matter of continuous debate.
Does total arterial coronary revascularization improve early surgical and hospital outcomes compared to conventional revascularization in patients undergoing primary elective CABG?
Cohort (n=60)
Does total arterial coronary revascularization improve early surgical and hospital outcomes compared to conventional revascularization in patients undergoing primary elective CABG?
Answers are grounded in this paper and cite their sources.
Total arterial revascularization in elective CABG is associated with shorter procedural times, reduced hospital stay, and improved mid-term symptom relief compared to conventional grafting.
Background: The superiority of total arterial revascularization over the conventional method is a matter of continuous debate. Therefore, we aimed to compare early surgical and hospital outcomes of the total artery and conventional revascularization strategies in patients undergoing coronary artery bypass grafting (CABG). Methods: The study included 60 patients who underwent primary elective CABG from 2018 to 2020. Patients were grouped according to the revascularization strategy into two groups. Group 1 included patients who had conventional revascularization using left internal mammary artery (LIMA) and vein grafts (n= 30), and group 2 included patients who had total arterial coronary revascularization (TACR) (n= 30). Results: Patient who had TACR were significantly younger (48.43 ± 11.72 vs. 55.63 ± 3.97 years; P= 0.003). TACR patients had shorter cardiopulmonary bypass (53.70 ± 9.91 vs 61.83 ± 9.60 min; P= 0.002) and ischemia times (38.20 ± 7.78 vs 44.03 ± 7.23 min; P= 0.004). Blood loss and transfusion were significantly higher in patients in the conventional group (P= 0.01 and ˂0.001, respectively). TACR was associated with shorter mechanical ventilation (3.83 ± 0.95 vs. 4.80 ± 1.40 hours; P= 0.003), ICU (1.13 ± 0.35 vs. 1.47 ± 0.51 days; P= 0.004) and hospital stay (4.47 ± 0.63 vs. 6.04 ± 0.71 days; P= 0.001). After six months, angina and dyspnea classes were significantly better in the TACR group. Conclusions: The debate about the optimal CABG conduit is ongoing. Total arterial revascularization could be associated with favorable short and mid-term results.
No takes yet. Share an insight, caveat, or question.
Elgharabawi et al. (2022) conducted a cohort in Coronary artery disease requiring CABG (n=60). Total arterial coronary revascularization (TACR) vs. Conventional revascularization using left internal mammary artery (LIMA) and vein grafts was evaluated on Hospital stay (days) (p=0.001). Total arterial coronary revascularization was associated with shorter hospital stay and better 6-month angina and dyspnea classes compared to conventional CABG.
Synapse has enriched 10 related papers. Consider them for comparative context: